We are developing a groundbreaking device platform for autonomous and miniaturized cell therapy production, significantly increasing capacity and reducing costs

85%

complete remission in r/r ALL patients
after a cell therapy treatment

44%

still cancer free, four years after a single infusion of a cell therapy

3%

of all eligible cancer patients receive a cell therapy

320K

price in EUR of a cell therapy
Kymriah, Germany 2020

Autonomy

Control intelligence enables the platform to autonomously perform processing and product control for each batch without human interaction

Miniaturization

Semiconductor chip technology and microfluidics enable processing with an unprecedentedly small footprint and cell-level certainty

Modularity

Functional modules allow for individual process designs for various cell types, offering conceptual flexibility